Expression of metabolically targeted biomarkers in endometrial carcinoma
Authors:
- 1 January 2010
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 116 (1) , 21-27
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Molecular alterations of EGFR and PIK3CA in uterine serous carcinomaGynecologic Oncology, 2009
- A catabolic block does not sufficiently explain how 2-deoxy-d-glucose inhibits cell growthProceedings of the National Academy of Sciences, 2008
- Sugar and fat – that's where it's at: metabolic changes in tumorsBreast Cancer Research, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- GLUT1 and GLUT8 in endometrium and endometrial adenocarcinomaLaboratory Investigation, 2006
- An expanding role for mTOR in cancerTrends in Molecular Medicine, 2005
- Akt Maintains Cell Size and Survival by Increasing mTOR-dependent Nutrient UptakeMolecular Biology of the Cell, 2002
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- On the Origin of Cancer CellsScience, 1956